The article discusses the role of body fat distribution in cardiovascular disease (CVD) risk, emphasizing that obesity is not a uniform condition but varies significantly in its effects on health. While traditional risk factors like smoking, hypertension, and high cholesterol have been effective in reducing CVD mortality, modern issues such as obesity and type 2 diabetes have emerged as new significant risk factors. The distribution of body fat, particularly visceral fat, plays a crucial role in metabolic health and CVD risk. Visceral fat is more closely associated with metabolic complications like insulin resistance, dyslipidemia, and inflammation than subcutaneous fat. Imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) have shown that visceral fat accumulation is a key driver of cardiometabolic risk. The article highlights that body mass index (BMI) alone is insufficient to assess CVD risk, as it does not distinguish between visceral and subcutaneous fat. Waist circumference and other anthropometric measures can provide additional insights, but they are not always reliable. The "hypertriglyceridemic waist" concept, which combines elevated triglycerides with an enlarged waist, is a useful marker for visceral fat. The article also discusses the role of other ectopic fat depots, such as liver fat and epicardial fat, in CVD risk. These fat depots are associated with various metabolic and cardiovascular complications. The relationship between body fat distribution and CVD risk is complex, and further research is needed to fully understand the mechanisms and develop effective interventions. In conclusion, the distribution of body fat, particularly visceral fat, is a critical factor in CVD risk. Assessing and managing this distribution is essential for effective CVD prevention and treatment. Future research should focus on understanding the role of different fat depots and developing targeted interventions to reduce cardiometabolic risk.The article discusses the role of body fat distribution in cardiovascular disease (CVD) risk, emphasizing that obesity is not a uniform condition but varies significantly in its effects on health. While traditional risk factors like smoking, hypertension, and high cholesterol have been effective in reducing CVD mortality, modern issues such as obesity and type 2 diabetes have emerged as new significant risk factors. The distribution of body fat, particularly visceral fat, plays a crucial role in metabolic health and CVD risk. Visceral fat is more closely associated with metabolic complications like insulin resistance, dyslipidemia, and inflammation than subcutaneous fat. Imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) have shown that visceral fat accumulation is a key driver of cardiometabolic risk. The article highlights that body mass index (BMI) alone is insufficient to assess CVD risk, as it does not distinguish between visceral and subcutaneous fat. Waist circumference and other anthropometric measures can provide additional insights, but they are not always reliable. The "hypertriglyceridemic waist" concept, which combines elevated triglycerides with an enlarged waist, is a useful marker for visceral fat. The article also discusses the role of other ectopic fat depots, such as liver fat and epicardial fat, in CVD risk. These fat depots are associated with various metabolic and cardiovascular complications. The relationship between body fat distribution and CVD risk is complex, and further research is needed to fully understand the mechanisms and develop effective interventions. In conclusion, the distribution of body fat, particularly visceral fat, is a critical factor in CVD risk. Assessing and managing this distribution is essential for effective CVD prevention and treatment. Future research should focus on understanding the role of different fat depots and developing targeted interventions to reduce cardiometabolic risk.